References
- American College of Obstetricians and Gynecologists. 2011. Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Obstetrics and Gynecology 118:1465–1468.
- Audibert F, Salomon LJ, Castaigne-Meary V, Alves K, Frydman R. 2003. Selective termination of a twin pregnancy as a treatment of severe pre-eclampsia. British Journal of Obstetrics and Gynecology 110:68–69.
- Audibert F, Saloman LJ, Frydman R. 2005. Selective fetocide reverses preeclampsia in discordant twins. American Journal of Obstetrics and Gynecology 193:894–895.
- Heyborne KD, Porreco RP. 2004. Selective fetocide reverses preeclampsia in discordant twins. American Journal of Obstetrics and Gynecology 191:477–480.
- Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A, Abrahamowicz M, et al. 2001. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 108:E35.
- Magee LA, Yong PJ, Espinosa V, Cote AM, Chen I, von Dadelszen P. 2009. Expectant management of severe preeclampsia remote from term: a structured systematic review. Hypertens Pregnancy 28:312–347.
- Society for Maternal Fetal Medicine. 2011. Evaluation and management of severe preeclampsia before 34 weeks’ gestation. American Journal of Obstetrics and Gynecology 205:191–198.
- van Runnard Heimel PJ, Huisjes AJ, Franx A, Koopman C, Bots ML, Bruinse HW. 2006. A randomised placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term. European Journal of Obstetrics & Gynecology 128:187–193.
- Woudstra, DM, Chandra, S, Hofmeyr, GJ, Dowswell, T. 2010. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database of Systematic Reviews 8:CD008148.